A critical beat in eosinophilic granulomatosis with polyangiitis

Rheumatology (Oxford). 2021 Jun 17;60(Suppl 3):iii28-iii31. doi: 10.1093/rheumatology/keab180.

Authors

Allyson C Egan^{1

2}, James Peters³, Elaine Jolly¹, Shaun Flint¹, Pasupathy Sivasothy¹, David R W Jayne^{1

2}

Affiliations

¹ Department of Medicine, Vasculitis and Lupus Centre, Cambridge University Hospital, Cambridge, UK.
² Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, London, UK.
³ Department of Immunology and Inflammation, Centre of Inflammatory Disease, Imperial College London, London, UK.

PMID: 34137885
DOI: 10.1093/rheumatology/keab180

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Alemtuzumab / administration & dosage
Antineoplastic Agents, Immunological / administration & dosage
Eosinophilia / complications*
Eosinophilia / diagnostic imaging
Eosinophilia / drug therapy
Glucocorticoids / administration & dosage
Granulomatosis with Polyangiitis / diagnostic imaging*
Granulomatosis with Polyangiitis / drug therapy
Humans
Male
Methylprednisolone / administration & dosage
Myocarditis / complications*
Myocarditis / drug therapy

Substances

Antineoplastic Agents, Immunological
Glucocorticoids
Alemtuzumab
Methylprednisolone